SENSOCURE
Real-time detection of ischemia before irreversible injury
Norway · Founded 2011 · $6.1M raised
- Employees
- 1–10
- Founded
- 2011
- Business Model
- B2B
- Website
- sensocure.no
- Total Funding
- $6.1M
- Last Round
- $2.2M Venture RoundFeb 2025
- Rounds
- 5
About
Sensocure is a Norwegian medical technology company established in 2011 that develops biomedical sensors for healthcare. Its flagship product, IscAlert™, is the world's first implantable micro-sensor that monitors local tissue pCO₂ continuously, enabling clinicians to detect the onset of ischemic events in real time before irreversible tissue damage occurs. The company has received investment from the EIC Fund and is targeting commercialization of IscAlert across surgical and critical care settings.
Summary
SENSOCURE is a Healthcare company based in Norway, founded in 2011. It has raised $6.1M in total across 5 rounds, most recently a $2.2M Venture Round round in Feb 2025. Investors include European Innovation Council Fund and Innovation Norway.
Funding History
Feb 2025
Sign up to see all 5 rounds
Grant through Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sensocure"><img src="https://indexed.vc/api/badge/company/sensocure" alt="SENSOCURE on Indexed.vc" width="260" height="76" /></a>